 adren ovarian steroid hormon gonadotropin-releas hormon agonist treatment polycyst ovari syndrom polycyst ovari syndrom ovarian steroid adren steroidogenesi hypothesi basal dexamethasone-suppressed-corticotropin-stimul steroid hormon respons group women gonadotropin-releas hormon agonist treatment month group women polycyst ovari syndrom high dehydroepiandrosteron sulfat level micrograms/dl women polycyst ovari syndrom normal dehydroepiandrosteron sulfat level micrograms/dl normal ovulatori women respons gonadotropin-releas hormon agonist basal serum hormon follicle-stimul hormon estradiol estron androstenedion testosteron group similar level basal dehydroepiandrosteron sulfat level group high level normal unalt concentr group subject polycyst ovari syndrom group high level declin basal serum dehydroepiandrosteron sulfat level evid beta-hydroxysteroid dehydrogenas defici treatment end treatment group polycyst ovari syndrom increas maximum increment rise dehydroepiandrosteron dehydroepiandrosteron sulfat level respons pharmacolog dose corticotropin dexamethasone-suppress baselin adren androgen capac unalt gonadotropin-releas hormon agonist administr ovarian steroid excess adren androgen secret women polycyst ovari syndrom beta-hydroxysteroid dehydrogenas defici mechan adren involv women polycyst ovari syndrom adren androgen capac